|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:available_on
|
generic version
|
|
gptkbp:brand
|
gptkb:Concerta
|
|
gptkbp:clinical_trial
|
long-term safety
ADHD treatment efficacy
comparison with other stimulants
|
|
gptkbp:contraindication
|
gptkb:Ophthalmology
heart problems
history of drug abuse
|
|
gptkbp:counseling_services
|
avoid alcohol
do not crush or chew
take as prescribed
report any heart problems
|
|
gptkbp:dosage_form
|
18 mg tablet
27 mg tablet
36 mg tablet
54 mg tablet
|
|
gptkbp:duration
|
up to 12 hours
|
|
gptkbp:form
|
extended-release tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Concerta
|
|
gptkbp:ingredients
|
gptkb:Sannin
|
|
gptkbp:interacts_with
|
antidepressants
MAO inhibitors
blood pressure medications
|
|
gptkbp:invention
|
2025
|
|
gptkbp:is_monitored_by
|
blood pressure
heart rate
growth in children
|
|
gptkbp:lifespan
|
3 to 4 hours
|
|
gptkbp:manufacturer
|
gptkb:Janssen_Pharmaceuticals
|
|
gptkbp:marketed_as
|
gptkb:2000
|
|
gptkbp:performance
|
Schedule II controlled substance
|
|
gptkbp:premiered_on
|
1 to 2 hours
|
|
gptkbp:related_products
|
gptkb:Strattera
gptkb:Ritalin
gptkb:Adderall
gptkb:Vyvanse
gptkb:Dexedrine
|
|
gptkbp:requires
|
gptkb:true
|
|
gptkbp:route_of_administration
|
oral
|
|
gptkbp:side_effect
|
decreased appetite
insomnia
dry mouth
nervousness
stomach pain
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:symptoms
|
seizures
hallucinations
rapid heartbeat
agitation
|
|
gptkbp:used_for
|
gptkb:Attention_Deficit_Hyperactivity_Disorder_(ADHD)
|
|
gptkbp:bfsParent
|
gptkb:Sannin
|
|
gptkbp:bfsLayer
|
5
|